Iovance Biotherapeutics Potential Upside
| IOVA Stock | | | USD 3.71 0.09 2.49% |
Potential Upside is the amount of upward price movement an investor or an analyst expects of a particular equity instrument. Below is Iovance Biotherapeutics's current Potential Upside with peer comparisons and related risk metrics.
Current Potential Upside Value
At 13.24, Iovance Biotherapeutics's Potential Upside indicates moderate estimated upside from current levels. Iovance Biotherapeutics trades below the model-derived fair value estimate by a meaningful margin.
Potential Upside | = | 1PM2PM |
| = | 13.24 | |
| 1PM | = | First upper moment |
| 2PM | = | Second upper moment |
Potential Upside Peers Comparison
Among sector peers, Iovance Biotherapeutics's Potential Upside of 13.24 is above the 8.94 group average. The range runs from 3.02 (Astria Therapeutics) to 21.2 (Replimune Group). Iovance Biotherapeutics shows greater estimated upside from current levels than the peer average.
Potential Upside Relative To Other Indicators
The chart below plots Potential Upside against Maximum Drawdown for Iovance Biotherapeutics and its peers. Each point represents one equity — position along the horizontal axis shows Potential Upside while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Iovance Biotherapeutics's Maximum Drawdown of
46.70 runs about
3.53 times its Potential Upside of
13.24 . This indicates Maximum Drawdown is significantly higher than Potential Upside for Iovance Biotherapeutics.
Methodology, Assumptions & Data Sources
The current Potential Upside for Iovance Biotherapeutics is 13.24. Iovance Biotherapeutics' Potential Upside is computed from historical closing prices over the selected time horizon, applying the indicator's defined mathematical transformation to raw price data. Inputs are drawn from end-of-day closing prices reported by supported exchanges, adjusted for splits and dividends where applicable. Iovance Biotherapeutics operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. The output reflects the selected calculation window — changing the horizon will produce different readings. This stock metric is provided for analytical reference.
Other Technical Indicators